Literature DB >> 17384481

Prenatal genetic diagnosis of severe perinatal (lethal) hypophosphatasia.

Atsushi Watanabe1, Seiichi Yamamasu, Toshiya Shinagawa, Yumi Suzuki, Hidehiko Miyake, Toshiyuki Takeshita, Hideo Orimo, Takashi Shimada.   

Abstract

Hypophosphatasia is an inherited disorder characterized by defective bone mineralization and a deficiency in tissue-nonspecific alkaline phosphatase (TNSALP) activity. This disorder is caused by various mutations of the TNSALP gene. We report here the prenatal diagnosis of the perinatal (lethal) type of hypophosphatasia in a sibling of an affected infant. The infant had been found to have hypophosphatasia on the basis of both clinical and radiologic manifestations and the finding of a homozygous single T nucleotide deletion at 1559 (1559delT) of the TNSALP gene on molecular analysis. Both parents were carriers with a heterozygous mutation in the same position, although they were not consanguineous. After their next child had been conceived, fetal genomic DNA was extracted from cultured cells of amniotic fluid at 15 weeks' gestation. The fetus had a homozygous 1559delT mutation. An ultrasonography examination at 19 weeks' gestation showed marked hypomineralization of all bony structures. A prenatal genetic diagnosis for hypophosphatasia in combination with ultrasonography is thus considered to be useful for confirming the diagnosis of hypophosphatasia, which presents with a wide variety of phenotypes. As a result, prenatal genetic counseling for hypophosphatasia with collaboration between obstetricians and clinical genetics teams.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17384481     DOI: 10.1272/jnms.74.65

Source DB:  PubMed          Journal:  J Nippon Med Sch        ISSN: 1345-4676            Impact factor:   0.920


  4 in total

Review 1.  Hypophosphatasia: an overview of the disease and its treatment.

Authors:  M L Bianchi
Journal:  Osteoporos Int       Date:  2015-08-06       Impact factor: 4.507

2.  Prevention of Lethal Murine Hypophosphatasia by Neonatal Ex Vivo Gene Therapy Using Lentivirally Transduced Bone Marrow Cells.

Authors:  Osamu Iijima; Koichi Miyake; Atsushi Watanabe; Noriko Miyake; Tsutomu Igarashi; Chizu Kanokoda; Aki Nakamura-Takahashi; Hideaki Kinoshita; Taku Noguchi; Shinichi Abe; Sonoko Narisawa; José Luis Millán; Takashi Okada; Takashi Shimada
Journal:  Hum Gene Ther       Date:  2015-11-19       Impact factor: 5.695

Review 3.  Hypophosphatasia.

Authors:  Etienne Mornet
Journal:  Orphanet J Rare Dis       Date:  2007-10-04       Impact factor: 4.123

4.  Six ALPL gene variants in five children with hypophosphatasia.

Authors:  Na Su; Min Zhu; Xinran Cheng; Ke Xu; Roland Kocijan; Huijiao Zhang
Journal:  Ann Transl Med       Date:  2021-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.